Pharmacogenomics of weight loss with sibutramine in obese and overweight patients
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2008
At a glance
- Drugs Sibutramine (Primary)
- Indications Obesity
- Focus Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 26 Dec 2007 Status changed from recruiting to completed.
- 09 Mar 2007 New trial record.